Atlantic Coast Retina Club/Macula 2026: Wet AMD
Justin Muste, MD Wills Eye Hospital, Philadelphia, PA The second Macula 2026 session was moderated by Drs. Julia A. Haller, MD and Johanna M. Seddon, MD, ScM, FASRS. The session…
Category: AMD
Atlantic Coast Retina Club/Macula 2026: Dry AMD
Timothy T. Xu, MD Wills Eye Hospital, Philadelphia, PA The dry age-related macular degeneration session of Atlantic Coast Retina Club 2026 was moderated by Alexander J. Brucker, MD and Jason…
AAO Retina Subday 2025: Shaping the Future of Diabetic Retinopathy Treatment
Ashley Zhou, MD Mayo Clinic, Rochester, MN At AAO 2025’s Retina Subspecialty Day, a pair of presentations delivered compelling new data on emerging strategies for diabetic retinopathy. Dr. Victor H.…
AAO Subday 2025: Hope for IRDs – From Optogenetics to Oral Therapies in Late-Breaking Data
Lyna Azzouz, MD Byers Eye Institute, Stanford University, Palo Alto, CA Late-breaking data presented at AAO 2025 highlighted emerging gene-independent treatment strategies for inherited retinal diseases. Allen C. Ho, MD…
Retina Society 2025 – Late Breaking II Session: Novel treatments for nAMD and CRAO
Turner D. Wibbelsman, MD Ophthalmology Resident Wills Eye Hospital The Retina Society 58th Annual Scientific Meeting featured two Late Breaking Sessions. On Friday September 12th, the late breaking session involved…
Retina Society 2025: AMD Session
Raziyeh Mahmoudzadeh, MD Virginia Commenwealth University The age-related macular degeneration (AMD) session on Thursday September 11th was moderated by Dr. Deeba Hussain and Dr. Thomas Wubben. Here we summarize the…
Retina Society 2025: Late Breaking Presentations I
Maryam Zekavat, MD, PhD Mass Eye & Ear At the Retina Society 2025 meeting in Chicago, the two late-breaking sessions highlighted innovations in retinal stem cell and prosthetic technologies for…
ASRS 2025: Dry AMD
Warren Pan, MD, PhD Kellogg Eye Center, Ann Arbor, MI The Dry AMD Session 3 at ASRS 2025 showcased groundbreaking clinical trials for geographic atrophy (GA) secondary to AMD, featuring novel therapies targeting complement…